Phase Ib of Cyclophosphamide, Pomalidomide, Dexamethasone and Daratumumab (CPD-DARA) in patients with relapsed/refractory multiple myeloma. (The CPD-DARA Study).

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516945-37-00

Acronym

CTRIAL-IE 19-17

Enrollment

Registered

2024-10-29

Start date

2021-11-04

Completion date

2025-09-09

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed/ refractory multiple myeloma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Ireland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026